Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity
Journal of Pharmacy and Pharmacology · 07.02.2026 · 78 (2)
DOI: 10.1093/jpp/rgaf106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 07.11.2025. Verfasst von Jônatas Felipe Dos Santos Almeida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-691, Brazil. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Propolis, Macrophages, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: São Paulo Research Foundation.
Abstract (Originalsprache)
Objectives
Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium found in hospital-acquired infections, particularly in immunosuppressed individuals. Brazilian red propolis is a beekeeping product with antimicrobial and immunomodulatory properties. Its composition includes flavonoids and benzophenones, such as oblongifolin B (OBLB). This study investigated the antibacterial activity of OBLB isolated from Brazilian red propolis against MRSA in vitro and its modulatory effects on macrophages.
Methods
The activity of OBLB was assessed both alone and in combination with antimicrobials. The minimum inhibitory and minimum bactericidal concentrations were determined for the USA300 MRSA strain and for a clinical isolate. The interaction between OBLB and the antimicrobials against MRSA was analysed using the checkerboard method. The effects of OBLB on THP-1 cells differentiated into macrophages were analysed regarding cytokine and eicosanoid production, cell surface marker expression, bactericidal activity, and hydrogen peroxide production. Key findings OBLB exhibited anti-MRSA activity and had no synergistic effects with antimicrobials or cytotoxic effects on macrophages. It stimulated tumor necrosis factor-α and interleukin-1β production, CD80 expression, and increased the bactericidal activity of macrophages suppressed or not by dexamethasone against MRSA.
Conclusions
OBLB exerted anti-MRSA properties and modulated macrophage activity, suggesting it is a potential candidate in new therapeutic approaches for MRSA infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-691, Brazil.
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto 14040-903, Brazil.
Förderung
- São Paulo Research Foundation
Zitieren
APA
Dos Santos Almeida, J. F., da Silva Honorio, M., Lopes, E. C., Ripari, N., Júnior, A. F., Tanimoto, M. H., Bastos, J. K., & Sforcin, J. M. (2026). Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity. Journal of Pharmacy and Pharmacology, 78(2). https://doi.org/10.1093/jpp/rgaf106
Vancouver
Dos Santos Almeida JF, da Silva Honorio M, Lopes EC, Ripari N, Júnior AF, Tanimoto MH, et al. Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity. Journal of Pharmacy and Pharmacology. 2026;78(2). doi:10.1093/jpp/rgaf106
BibTeX
@article{DosSantosAlmeida2026,
author = {Dos Santos Almeida, Jônatas Felipe and da Silva Honorio, Mariana and Lopes, Emilly Camargo and Ripari, Nicolas and Júnior, Ary Fernandes and Tanimoto, Matheus Hikaru and Bastos, Jairo Kenupp and Sforcin, José Maurício},
title = {Oblongifolin B isolated from Brazilian red propolis exhibits anti-methicillin-resistant Staphylococcus aureus action and modulates macrophage activity},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {2},
doi = {10.1093/jpp/rgaf106}
}
EUVIMED